Siegfried Holding AG SFZN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SFZN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CHF 916.00
- Day Range
- CHF 915.00–930.00
- 52-Week Range
- CHF 655.00–950.00
- Bid/Ask
- CHF 930.00 / CHF 933.00
- Market Cap
- CHF 3.98 Bil
- Volume/Avg
- 10,410 / 5,931
Key Statistics
- Price/Earnings (Normalized)
- 25.21
- Price/Sales
- 3.14
- Dividend Yield (Trailing)
- 0.39%
- Dividend Yield (Forward)
- 0.39%
- Total Yield
- 0.52%
Company Profile
Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,180
- Website
- https://www.siegfried.ch
Comparables
Valuation
|
Metric
|
SFZN
|
PPGN
|
DESN
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.21 | — | 45.16 |
Price/Book Value | 5.20 | 3.02 | 4.02 |
Price/Sales | 3.14 | 3.43 | 10.92 |
Price/Cash Flow | 18.09 | — | 34.82 |
Price/Earnings
SFZN
PPGN
DESN
Financial Strength
|
Metric
|
SFZN
|
PPGN
|
DESN
|
|---|---|---|---|
Quick Ratio | 1.35 | 1.09 | 1.65 |
Current Ratio | 2.47 | 1.85 | 2.56 |
Interest Coverage | 17.11 | −9.37 | 56.42 |
Quick Ratio
SFZN
PPGN
DESN
Profitability
|
Metric
|
SFZN
|
PPGN
|
DESN
|
|---|---|---|---|
Return on Assets (Normalized) | 7.09% | −6.13% | 8.08% |
Return on Equity (Normalized) | 17.53% | −9.58% | 10.81% |
Return on Invested Capital (Normalized) | 10.47% | −7.07% | 10.12% |
Return on Assets
SFZN
PPGN
DESN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Xswsscsqc | Bwgwn | $81.1 Bil | |||
| Zoetis Inc Class A
ZTS
| Nytccsnrtf | Nnkq | $80.7 Bil | |||
| Haleon PLC ADR
HLN
| Cxzvwsxll | Rzgh | $38.6 Bil | |||
| Viatris Inc
VTRS
| Tclnrvpl | Hbrm | $12.5 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Nrpzrhns | Vbt | $12.1 Bil | |||
| Catalent Inc
CTLT
| Ylxyjkxh | Shnzqh | $10.2 Bil | |||
| Perrigo Co PLC
PRGO
| Rzzzqqt | Myvg | $3.7 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Fbyrvgts | Tbwh | $3.4 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Fnjblrt | Jjqfnh | $3.3 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Slxklcct | Mjsf | $2.9 Bil |